Duane Morris Partner Vicki G. Norton, Ph.D., will be speaking at the Personalized Cancer Vaccine Summit in Boston on Thursday, November 20. She will be on the panel “Health Economics, IP & Early Access: Navigating Legal Grey Zones in the Race to Personalized Cancer Vaccines.” The panel will discuss:
- How emerging legal frameworks, such as Montana’s Right To Try, could impact patient access to unapproved personalized vaccines and what that means for regulatory strategy.
- Balancing IP protection vs. platform flexibility in an era where proprietary algorithms, tumor-specific libraries, and bioinformatic tools are central to value creation.
- The role of patent exclusivity, trade secrets, and data protection in enabling commercial viability for PCVs – especially when facing fragmented regulatory landscapes.